Finance

Lists
BIM:EPA
BioMerieux SA
78,15 €
+1,82%
(+1,40) 1D
5 ოქტ, 17:35:11 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BIM...
Open
76,45 €
High
78,95 €
Low
76,45 €
Mkt. cap
9,29 მლრდ.
Avg. vol.
163,63 ათ.
Volume
141,50 ათ.
P/E ratio
20,03
52-wk high
116,70 €
52-wk low
65,60 €
EPS
3,90 €
Shares outstanding
118,36 მლნ.
No. of employees
15 ათ.
Open
76,45 €
High
78,95 €
Low
76,45 €
Mkt. cap
9,29 მლრდ.
Avg. vol.
163,63 ათ.
Volume
141,50 ათ.
P/E ratio
20,03
52-wk high
116,70 €
52-wk low
65,60 €
EPS
3,90 €
Shares outstanding
118,36 მლნ.
No. of employees
15 ათ.
News stories
From web sources and news partners
Ideal Investisseur
Ideal Investisseur
·
11 საათის წინ
At the forefront of the SBF 120, bioMérieux stock climbs 2%
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14,9 ათ.
Founded1963
HeadquartersMarcy-l'Étoile, რონა-ალპები, საფრანგეთი
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,01 მლრდ.
1,01 მლრდ.
982,30 მლნ.
982,30 მლნ.
Cost of goods sold
442,05 მლნ.
442,05 მლნ.
433,20 მლნ.
433,20 მლნ.
Cost of revenue
442,05 მლნ.
442,05 მლნ.
433,20 მლნ.
433,20 მლნ.
Research and development expenses
129,00 მლნ.
129,00 მლნ.
128,70 მლნ.
128,70 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
271,20 მლნ.
271,20 მლნ.
272,15 მლნ.
272,15 მლნ.
Operating expense
400,65 მლნ.
400,65 მლნ.
399,50 მლნ.
399,50 მლნ.
Total operating expenses
842,70 მლნ.
842,70 მლნ.
832,70 მლნ.
832,70 მლნ.
Operating income
170,30 მლნ.
170,30 მლნ.
149,60 მლნ.
149,60 მლნ.
Other non operating income
-
-
200,00 ათ.
200,00 ათ.
EBT including unusual items
156,25 მლნ.
156,25 მლნ.
147,30 მლნ.
147,30 მლნ.
EBT excluding unusual items
171,85 მლნ.
171,85 მლნ.
148,60 მლნ.
148,60 მლნ.
Income tax expense
38,10 მლნ.
38,10 მლნ.
34,40 მლნ.
34,40 მლნ.
Effective tax rate
24,38%
24,38%
23,35%
23,35%
Other operating expenses
-7,30 მლნ.
-7,30 მლნ.
-8,45 მლნ.
-8,45 მლნ.
Net income
118,25 მლნ.
118,25 მლნ.
113,05 მლნ.
113,05 მლნ.
Net profit margin
11,67%
11,67%
11,51%
11,51%
Earnings per share
-
-
-
-
Interest and investment income
3,30 მლნ.
3,30 მლნ.
3,95 მლნ.
3,95 მლნ.
Interest expense
-4,20 მლნ.
-4,20 მლნ.
-3,85 მლნ.
-3,85 მლნ.
Net interest expenses
-900,00 ათ.
-900,00 ათ.
100,00 ათ.
100,00 ათ.
Depreciation and amortization charges
7,75 მლნ.
7,75 მლნ.
-
-
EBITDA
327,00 მლნ.
327,00 მლნ.
207,75 მლნ.
207,75 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები